Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Activation During Sinus Rhythm in Ventricles With Healed Infarction: Differentiation Between Arrhythmogenic and Nonarrhythmogenic Scar.

Rottmann M, Kleber AG, Barkagan M, Sroubek J, Leshem E, Shapira-Daniels A, Buxton AE, Anter E.

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007879. doi: 10.1161/CIRCEP.119.007879. Epub 2019 Oct 10.

PMID:
31597477
2.

Flexible 3D Cell-Based Platforms for the Discovery and Profiling of Novel Drugs Targeting Plasmodium Hepatic Infection.

Arez F, Rebelo SP, Fontinha D, Simão D, Martins TR, Machado M, Fischli C, Oeuvray C, Badolo L, Carrondo MJT, Rottmann M, Spangenberg T, Brito C, Greco B, Prudêncio M, Alves PM.

ACS Infect Dis. 2019 Sep 13. doi: 10.1021/acsinfecdis.9b00144. [Epub ahead of print]

PMID:
31479238
3.

Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate.

Shapira-Daniels A, Barkagan M, Rottmann M, Sroubek J, Tugal D, Carlozzi MA, McConville JW, Buxton AE, Anter E.

Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e007336. doi: 10.1161/CIRCEP.119.007336.

PMID:
31113232
4.

Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.

Pölcher M, Rottmann M, Brugger S, Mahner S, Dannecker C, Kiechle M, Brambs C, Grab D, Anthuber C, von Koch F, Schnelzer A, Engel J.

Gynecol Oncol. 2019 Jul;154(1):65-71. doi: 10.1016/j.ygyno.2019.04.002. Epub 2019 Apr 23.

PMID:
31027900
5.

Expandable Lattice Electrode Ablation Catheter.

Barkagan M, Leshem E, Rottmann M, Sroubek J, Shapira-Daniels A, Anter E.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007090. doi: 10.1161/CIRCEP.118.007090.

PMID:
30943762
6.

Cell Penetration, Herbicidal Activity, and in-vivo-Toxicity of Oligo-Arginine Derivatives and of Novel Guanidinium-Rich Compounds Derived from the Biopolymer Cyanophycin.

Grogg M, Hilvert D, Ebert MO, Beck AK, Seebach D, Kurth F, Dittrich PS, Sparr C, Wittlin S, Rottmann M, Mäser P.

Helv Chim Acta. 2018 Oct;101(10). pii: e1800112. doi: 10.1002/hlca.201800112.

7.

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.

Baragaña B, Forte B, Choi R, Nakazawa Hewitt S, Bueren-Calabuig JA, Pisco JP, Peet C, Dranow DM, Robinson DA, Jansen C, Norcross NR, Vinayak S, Anderson M, Brooks CF, Cooper CA, Damerow S, Delves M, Dowers K, Duffy J, Edwards TE, Hallyburton I, Horst BG, Hulverson MA, Ferguson L, Jiménez-Díaz MB, Jumani RS, Lorimer DD, Love MS, Maher S, Matthews H, McNamara CW, Miller P, O'Neill S, Ojo KK, Osuna-Cabello M, Pinto E, Post J, Riley J, Rottmann M, Sanz LM, Scullion P, Sharma A, Shepherd SM, Shishikura Y, Simeons FRC, Stebbins EE, Stojanovski L, Straschil U, Tamaki FK, Tamjar J, Torrie LS, Vantaux A, Witkowski B, Wittlin S, Yogavel M, Zuccotto F, Angulo-Barturen I, Sinden R, Baum J, Gamo FJ, Mäser P, Kyle DE, Winzeler EA, Myler PJ, Wyatt PG, Floyd D, Matthews D, Sharma A, Striepen B, Huston CD, Gray DW, Fairlamb AH, Pisliakov AV, Walpole C, Read KD, Van Voorhis WC, Gilbert IH.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7015-7020. doi: 10.1073/pnas.1814685116. Epub 2019 Mar 20.

8.

The Hyperpolarization-Activated HCN4 Channel is Important for Proper Maintenance of Oscillatory Activity in the Thalamocortical System.

Zobeiri M, Chaudhary R, Blaich A, Rottmann M, Herrmann S, Meuth P, Bista P, Kanyshkova T, Lüttjohann A, Narayanan V, Hundehege P, Meuth SG, Romanelli MN, Urbano FJ, Pape HC, Budde T, Ludwig A.

Cereb Cortex. 2019 May 1;29(5):2291-2304. doi: 10.1093/cercor/bhz047.

9.

Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinoma.

Schmoeckel E, Hofmann S, Fromberger D, Rottmann M, Luthardt B, Burges A, Jeschke U, Kirchner T, Lax SF, Mayr D.

Virchows Arch. 2019 May;474(5):599-608. doi: 10.1007/s00428-019-02528-6. Epub 2019 Feb 7.

PMID:
30734108
10.

A novel octaray multielectrode catheter for high-resolution atrial mapping: Electrogram characterization and utility for mapping ablation gaps.

Sroubek J, Rottmann M, Barkagan M, Leshem E, Shapira-Daniels A, Brem E, Fuentes-Ortega C, Malinaric J, Basu S, Bar-Tal M, Anter E.

J Cardiovasc Electrophysiol. 2019 May;30(5):749-757. doi: 10.1111/jce.13867. Epub 2019 Feb 12.

PMID:
30723994
11.

Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs.

Martí Coma-Cros E, Biosca A, Marques J, Carol L, Urbán P, Berenguer D, Riera MC, Delves M, Sinden RE, Valle-Delgado JJ, Spanos L, Siden-Kiamos I, Pérez P, Paaijmans K, Rottmann M, Manfredi A, Ferruti P, Ranucci E, Fernàndez-Busquets X.

Pharmaceutics. 2018 Nov 10;10(4). pii: E225. doi: 10.3390/pharmaceutics10040225.

12.

Effect of Baseline Impedance on Ablation Lesion Dimensions.

Barkagan M, Rottmann M, Leshem E, Shen C, Buxton AE, Anter E.

Circ Arrhythm Electrophysiol. 2018 Oct;11(10):e006690. doi: 10.1161/CIRCEP.118.006690.

PMID:
30354405
13.

Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm.

Anter E, Kleber AG, Rottmann M, Leshem E, Barkagan M, Tschabrunn CM, Contreras-Valdes FM, Buxton AE.

JACC Clin Electrophysiol. 2018 Aug;4(8):1033-1048. doi: 10.1016/j.jacep.2018.04.007. Epub 2018 Jun 27.

14.

Potent Inhibitors of Plasmodial Serine Hydroxymethyltransferase (SHMT) Featuring a Spirocyclic Scaffold.

Schwertz G, Witschel MC, Rottmann M, Leartsakulpanich U, Chitnumsub P, Jaruwat A, Amornwatcharapong W, Ittarat W, Schäfer A, Aponte RA, Trapp N, Chaiyen P, Diederich F.

ChemMedChem. 2018 May 8;13(9):931-943. doi: 10.1002/cmdc.201800053. Epub 2018 Apr 14.

PMID:
29655285
15.

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.

Heckl M, Schmoeckel E, Hertlein L, Rottmann M, Jeschke U, Mayr D.

PLoS One. 2018 Feb 16;13(2):e0192881. doi: 10.1371/journal.pone.0192881. eCollection 2018.

16.

Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity.

Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B.

Eur J Med Chem. 2018 Feb 25;146:651-667. doi: 10.1016/j.ejmech.2018.01.062. Epub 2018 Jan 31.

PMID:
29407988
17.

COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE.

Weiss M, Sim DA, Herold T, Schumann RG, Liegl R, Kern C, Kreutzer T, Schiefelbein J, Rottmann M, Priglinger S, KortUEm KU.

Retina. 2018 Dec;38(12):2293-2300. doi: 10.1097/IAE.0000000000001892.

PMID:
29068914
18.

Conformational Aspects in the Design of Inhibitors for Serine Hydroxymethyltransferase (SHMT): Biphenyl, Aryl Sulfonamide, and Aryl Sulfone Motifs.

Schwertz G, Frei MS, Witschel MC, Rottmann M, Leartsakulpanich U, Chitnumsub P, Jaruwat A, Ittarat W, Schäfer A, Aponte RA, Trapp N, Mark K, Chaiyen P, Diederich F.

Chemistry. 2017 Oct 12;23(57):14345-14357. doi: 10.1002/chem.201703244. Epub 2017 Oct 2.

PMID:
28967982
19.

LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.

Schmoeckel E, Odai-Afotey AA, Schleißheimer M, Rottmann M, Flesken-Nikitin A, Ellenson LH, Kirchner T, Mayr D, Nikitin AY.

Mod Pathol. 2017 Sep;30(9):1241-1250. doi: 10.1038/modpathol.2017.53. Epub 2017 Jun 30.

20.

Antimalarial Inhibitors Targeting Serine Hydroxymethyltransferase (SHMT) with in Vivo Efficacy and Analysis of their Binding Mode Based on X-ray Cocrystal Structures.

Schwertz G, Witschel MC, Rottmann M, Bonnert R, Leartsakulpanich U, Chitnumsub P, Jaruwat A, Ittarat W, Schäfer A, Aponte RA, Charman SA, White KL, Kundu A, Sadhukhan S, Lloyd M, Freiberg GM, Srikumaran M, Siggel M, Zwyssig A, Chaiyen P, Diederich F.

J Med Chem. 2017 Jun 22;60(12):4840-4860. doi: 10.1021/acs.jmedchem.7b00008. Epub 2017 Jun 13.

PMID:
28537728
21.

Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.

Rottmann M, Burges A, Mahner S, Anthuber C, Beck T, Grab D, Schnelzer A, Kiechle M, Mayr D, Pölcher M, Schubert-Fritschle G, Engel J.

J Cancer Res Clin Oncol. 2017 Sep;143(9):1833-1844. doi: 10.1007/s00432-017-2422-6. Epub 2017 Apr 26.

PMID:
28447160
22.

An amphiphilic graft copolymer-based nanoparticle platform for reduction-responsive anticancer and antimalarial drug delivery.

Najer A, Wu D, Nussbaumer MG, Schwertz G, Schwab A, Witschel MC, Schäfer A, Diederich F, Rottmann M, Palivan CG, Beck HP, Meier W.

Nanoscale. 2016 Aug 21;8(31):14858-69. doi: 10.1039/c6nr04290b. Epub 2016 Jul 25.

PMID:
27452350
23.

Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030.

Quante AS, Ming C, Rottmann M, Engel J, Boeck S, Heinemann V, Westphalen CB, Strauch K.

Cancer Med. 2016 Sep;5(9):2649-56. doi: 10.1002/cam4.767. Epub 2016 Jun 29.

24.

Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysis.

Rottmann M, Beck T, Burges A, Dannecker C, Kiechle M, Mayr D, Schlesinger-Raab A, Schubert-Fritschle G, Engel J.

J Cancer Res Clin Oncol. 2016 Jun;142(6):1331-41. doi: 10.1007/s00432-016-2135-2. Epub 2016 Mar 14.

PMID:
26973058
25.

Gift from Nature: Cyclomarin A Kills Mycobacteria and Malaria Parasites by Distinct Modes of Action.

Bürstner N, Roggo S, Ostermann N, Blank J, Delmas C, Freuler F, Gerhartz B, Hinniger A, Hoepfner D, Liechty B, Mihalic M, Murphy J, Pistorius D, Rottmann M, Thomas JR, Schirle M, Schmitt EK.

Chembiochem. 2015 Nov;16(17):2433-6. doi: 10.1002/cbic.201500472. Epub 2015 Oct 16.

PMID:
26472355
26.

Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry.

Schlesinger-Raab A, Mihaljevic AL, Egert S, Emeny R, Jauch KW, Kleeff J, Novotny A, Nüssler NC, Rottmann M, Schepp W, Schmitt W, Schubert-Fritschle G, Weber B, Schuhmacher C, Engel J.

Gastric Cancer. 2016 Jul;19(3):713-22. doi: 10.1007/s10120-015-0527-7. Epub 2015 Aug 11.

PMID:
26260874
27.

Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities.

Witschel MC, Rottmann M, Schwab A, Leartsakulpanich U, Chitnumsub P, Seet M, Tonazzi S, Schwertz G, Stelzer F, Mietzner T, McNamara C, Thater F, Freymond C, Jaruwat A, Pinthong C, Riangrungroj P, Oufir M, Hamburger M, Mäser P, Sanz-Alonso LM, Charman S, Wittlin S, Yuthavong Y, Chaiyen P, Diederich F.

J Med Chem. 2015 Apr 9;58(7):3117-30. doi: 10.1021/jm501987h. Epub 2015 Mar 18.

PMID:
25785478
28.

Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model.

Lakshminarayana SB, Freymond C, Fischli C, Yu J, Weber S, Goh A, Yeung BK, Ho PC, Dartois V, Diagana TT, Rottmann M, Blasco F.

Antimicrob Agents Chemother. 2015 Feb;59(2):1200-10. doi: 10.1128/AAC.03274-14. Epub 2014 Dec 8.

29.

Heterochromatin protein 1 secures survival and transmission of malaria parasites.

Brancucci NMB, Bertschi NL, Zhu L, Niederwieser I, Chin WH, Wampfler R, Freymond C, Rottmann M, Felger I, Bozdech Z, Voss TS.

Cell Host Microbe. 2014 Aug 13;16(2):165-176. doi: 10.1016/j.chom.2014.07.004.

30.

A Progress Report of the IFCC Committee for Standardization of Thyroid Function Tests.

Thienpont LM, Van Uytfanghe K, Van Houcke S, Das B, Faix JD, MacKenzie F, Quinn FA, Rottmann M, Van den Bruel A; IFCC Committee for Standardization of Thyroid Function Tests (C-STFT).

Eur Thyroid J. 2014 Jun;3(2):109-16. doi: 10.1159/000358270. Epub 2014 May 7.

31.

KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.

Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, Chen Z, Francek C, Wu T, Nagle A, Barnes SW, Plouffe D, Lee MC, Fidock DA, Graumans W, van de Vegte-Bolmer M, van Gemert GJ, Wirjanata G, Sebayang B, Marfurt J, Russell B, Suwanarusk R, Price RN, Nosten F, Tungtaeng A, Gettayacamin M, Sattabongkot J, Taylor J, Walker JR, Tully D, Patra KP, Flannery EL, Vinetz JM, Renia L, Sauerwein RW, Winzeler EA, Glynne RJ, Diagana TT.

Antimicrob Agents Chemother. 2014 Sep;58(9):5060-7. doi: 10.1128/AAC.02727-13. Epub 2014 Jun 9.

32.

Deorphaning pyrrolopyrazines as potent multi-target antimalarial agents.

Reker D, Seet M, Pillong M, Koch CP, Schneider P, Witschel MC, Rottmann M, Freymond C, Brun R, Schweizer B, Illarionov B, Bacher A, Fischer M, Diederich F, Schneider G.

Angew Chem Int Ed Engl. 2014 Jul 1;53(27):7079-84. doi: 10.1002/anie.201311162. Epub 2014 Jun 4.

PMID:
24895172
33.

Level of hospital care and outcome of gastric cancer: a population-based evaluation of the Munich Cancer Registry.

Schlesinger-Raab A, Mihaljevic AL, Egert S, Emeny RT, Jauch KW, Kleeff J, Novotny A, Nüssler NC, Rottmann M, Schepp W, Schmitt W, Schubert-Fritschle G, Weber B, Schuhmacher C, Engel J.

J Cancer Res Clin Oncol. 2014 May;140(5):789-800. doi: 10.1007/s00432-014-1632-4. Epub 2014 Mar 15.

PMID:
24633864
34.

Pseudilins: halogenated, allosteric inhibitors of the non-mevalonate pathway enzyme IspD.

Kunfermann A, Witschel M, Illarionov B, Martin R, Rottmann M, Höffken HW, Seet M, Eisenreich W, Knölker HJ, Fischer M, Bacher A, Groll M, Diederich F.

Angew Chem Int Ed Engl. 2014 Feb 17;53(8):2235-9. doi: 10.1002/anie.201309557. Epub 2014 Jan 20.

PMID:
24446431
35.

Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium.

Urbán P, Valle-Delgado JJ, Mauro N, Marques J, Manfredi A, Rottmann M, Ranucci E, Ferruti P, Fernàndez-Busquets X.

J Control Release. 2014 Mar 10;177:84-95. doi: 10.1016/j.jconrel.2013.12.032. Epub 2014 Jan 7.

PMID:
24412735
36.

Targeting Plasmodium PI(4)K to eliminate malaria.

McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ, Zeeman AM, Dechering KJ, Kumar TS, Henrich PP, Gagaring K, Ibanez M, Kato N, Kuhen KL, Fischli C, Nagle A, Rottmann M, Plouffe DM, Bursulaya B, Meister S, Rameh L, Trappe J, Haasen D, Timmerman M, Sauerwein RW, Suwanarusk R, Russell B, Renia L, Nosten F, Tully DC, Kocken CH, Glynne RJ, Bodenreider C, Fidock DA, Diagana TT, Winzeler EA.

Nature. 2013 Dec 12;504(7479):248-253. doi: 10.1038/nature12782. Epub 2013 Nov 27.

37.

Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii.

Kemp LE, Rusch M, Adibekian A, Bullen HE, Graindorge A, Freymond C, Rottmann M, Braun-Breton C, Baumeister S, Porfetye AT, Vetter IR, Hedberg C, Soldati-Favre D.

J Biol Chem. 2013 Sep 20;288(38):27002-18. doi: 10.1074/jbc.M113.460709. Epub 2013 Aug 2.

38.

Optimization of triazine nitriles as rhodesain inhibitors: structure-activity relationships, bioisosteric imidazopyridine nitriles, and X-ray crystal structure analysis with human cathepsin L.

Ehmke V, Winkler E, Banner DW, Haap W, Schweizer WB, Rottmann M, Kaiser M, Freymond C, Schirmeister T, Diederich F.

ChemMedChem. 2013 Jun;8(6):967-75. doi: 10.1002/cmdc.201300112. Epub 2013 May 9.

PMID:
23658062
39.

['Walkability' and physical activity - results of empirical studies based on the 'Neighbourhood Environment Walkability Scale (NEWS)'].

Rottmann M, Mielck A.

Gesundheitswesen. 2014 Feb;76(2):108-15. doi: 10.1055/s-0033-1338000. Epub 2013 Apr 9. German.

PMID:
23572473
40.

[Association between the social status of city districts and health risks: multilevel analyses concerning the regional distribution of overweight, hypertension and self-rated health in Augsburg, Germany].

Rottmann M, Maier W, von Klot S, Döring A, Mielck A.

Gesundheitswesen. 2013 Mar;75(3):134-9. doi: 10.1055/s-0032-1327739. Epub 2012 Dec 10. German.

PMID:
23229162
41.

Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes.

Aureggi V, Ehmke V, Wieland J, Schweizer WB, Bernet B, Bur D, Meyer S, Rottmann M, Freymond C, Brun R, Breit B, Diederich F.

Chemistry. 2013 Jan 2;19(1):155-64. doi: 10.1002/chem.201202941. Epub 2012 Nov 19.

PMID:
23161835
42.

Agrochemicals against malaria, sleeping sickness, leishmaniasis and Chagas disease.

Witschel M, Rottmann M, Kaiser M, Brun R.

PLoS Negl Trop Dis. 2012;6(10):e1805. doi: 10.1371/journal.pntd.0001805. Epub 2012 Oct 25.

43.

Genetic diversity of expressed Plasmodium falciparum var genes from Tanzanian children with severe malaria.

Mugasa J, Qi W, Rusch S, Rottmann M, Beck HP.

Malar J. 2012 Jul 16;11:230. doi: 10.1186/1475-2875-11-230.

44.

Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.

Gemma S, Camodeca C, Sanna Coccone S, Joshi BP, Bernetti M, Moretti V, Brogi S, Bonache de Marcos MC, Savini L, Taramelli D, Basilico N, Parapini S, Rottmann M, Brun R, Lamponi S, Caccia S, Guiso G, Summers RL, Martin RE, Saponara S, Gorelli B, Novellino E, Campiani G, Butini S.

J Med Chem. 2012 Aug 9;55(15):6948-67. doi: 10.1021/jm300802s. Epub 2012 Jul 27.

PMID:
22783984
45.

Antiparasitic agents: new drugs on the horizon.

Mäser P, Wittlin S, Rottmann M, Wenzler T, Kaiser M, Brun R.

Curr Opin Pharmacol. 2012 Oct;12(5):562-6. doi: 10.1016/j.coph.2012.05.001. Epub 2012 May 29. Review.

PMID:
22652215
46.

Imidazolopiperazines: lead optimization of the second-generation antimalarial agents.

Nagle A, Wu T, Kuhen K, Gagaring K, Borboa R, Francek C, Chen Z, Plouffe D, Lin X, Caldwell C, Ek J, Skolnik S, Liu F, Wang J, Chang J, Li C, Liu B, Hollenbeck T, Tuntland T, Isbell J, Chuan T, Alper PB, Fischli C, Brun R, Lakshminarayana SB, Rottmann M, Diagana TT, Winzeler EA, Glynne R, Tully DC, Chatterjee AK.

J Med Chem. 2012 May 10;55(9):4244-73. doi: 10.1021/jm300041e. Epub 2012 Apr 23.

47.

The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector.

van Pelt-Koops JC, Pett HE, Graumans W, van der Vegte-Bolmer M, van Gemert GJ, Rottmann M, Yeung BK, Diagana TT, Sauerwein RW.

Antimicrob Agents Chemother. 2012 Jul;56(7):3544-8. doi: 10.1128/AAC.06377-11. Epub 2012 Apr 16.

48.

Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.

Ehmke V, Quinsaat JE, Rivera-Fuentes P, Heindl C, Freymond C, Rottmann M, Brun R, Schirmeister T, Diederich F.

Org Biomol Chem. 2012 Aug 14;10(30):5764-8. doi: 10.1039/c2ob00034b. Epub 2012 Feb 16.

PMID:
22336919
49.

Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.

Meister S, Plouffe DM, Kuhen KL, Bonamy GM, Wu T, Barnes SW, Bopp SE, Borboa R, Bright AT, Che J, Cohen S, Dharia NV, Gagaring K, Gettayacamin M, Gordon P, Groessl T, Kato N, Lee MC, McNamara CW, Fidock DA, Nagle A, Nam TG, Richmond W, Roland J, Rottmann M, Zhou B, Froissard P, Glynne RJ, Mazier D, Sattabongkot J, Schultz PG, Tuntland T, Walker JR, Zhou Y, Chatterjee A, Diagana TT, Winzeler EA.

Science. 2011 Dec 9;334(6061):1372-7. doi: 10.1126/science.1211936. Epub 2011 Nov 17.

50.

Identification of 1,3-diiminoisoindoline carbohydrazides as potential antimalarial candidates.

Mombelli P, Witschel MC, van Zijl AW, Geist JG, Rottmann M, Freymond C, Röhl F, Kaiser M, Illarionova V, Fischer M, Siepe I, Schweizer WB, Brun R, Diederich F.

ChemMedChem. 2012 Jan 2;7(1):151-8. doi: 10.1002/cmdc.201100441. Epub 2011 Nov 16.

PMID:
22095896

Supplemental Content

Loading ...
Support Center